Amarin Corp. (AMRN) Reports Research Supporting Potential for VASCEPA to Reduce Major Adverse Cardiovascular (CV) Events and Associated Costs
Go back to Amarin Corp. (AMRN) Reports Research Supporting Potential for VASCEPA to Reduce Major Adverse Cardiovascular (CV) Events and Associated CostsAmarin Corp Plc (NASDAQ: AMRN) | Delayed: 0.89 +0.02 (2.30%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.87 | 52 Week High | $3.65 | |||
Open | $0.87 | 52 Week Low | $1.24 | |||
Day High | $0.89 | P/E | N/A | |||
Day Low | $0.87 | EPS | $0.00 | |||
Volume | 257,183 |